ERAS.NASDAQErasca, INC

Form 4: Director Jean I. Liu Acquires Stock Options in Erasca, Inc.

Sentiment:

SEC Form 4 Filing


Director Jean I. Liu of Erasca, Inc. was granted stock options in lieu of cash compensation for her board service in 2025.

Summary

  • Jean I. Liu, a director at Erasca, Inc., received 24,939 stock options on January 1, 2025.
  • These options were granted in place of cash compensation for her service on the board of directors and its committees in 2025.
  • The options have an exercise price of $2.51 per share.
  • The options will vest in monthly increments over a year, starting one month after the grant date, contingent on her continued board service.
  • The options expire on January 1, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating a neutral to slightly positive sentiment as it aligns director interests with shareholders.

Positives

  • The grant of stock options aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages continued service on the board.

Risks

  • The value of the options is dependent on the future performance of Erasca, Inc.'s stock price.
  • If the director leaves the board before the options fully vest, she may forfeit some of the options.

Future Outlook

The vesting of the options is contingent on the director's continued service on the board.

Management Comments

  • The option grant was issued in lieu of cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025.

Industry Context

Stock option grants are a common form of compensation for board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

  • Stock option grants are a standard practice for compensating board members across the biotechnology industry.
  • The vesting schedule of monthly increments over a year is typical for such grants.
  • The exercise price of $2.51 is specific to Erasca's stock and market conditions at the time of the grant.

Stakeholder Impact

  • The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
  • The vesting schedule encourages the director's continued service on the board.

Key Dates

DateDescription
01/01/2025Date of the stock option grant to Jean I. Liu.
01/02/2025Date of the filing of the SEC Form 4.
01/01/2035Expiration date of the stock options.

Keywords

stock options, director compensation, insider trading, Erasca Inc, board of directors, equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.